MicroPort NeuroTech Limited
MicroPort NeuroTech Limited engages in the research and development, production, and sale of neuro-interventional medical devices in the People's Republic of China and internationally. It offers NUMEN, a coil embolization system; NUMEN FR, a coil detachm…
Medical - Devices
CN, Shanghai [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
Metric | Q2 | Q4 | Δ in % | |
---|---|---|---|---|
Current Ratio | 0.00 | 5.35 | 5.35 | |
Debt/Assets | n.A. | n.A. | n.A. | |
Debt/Equity | n.A. | n.A. | n.A. | |
Net Debt/EBITDA | -100.00 | -4.25 | 0.00 | |
Naive Interpretation | member |
2
Per Share
Metric | Q2 | Q4 | Δ in % | |
---|---|---|---|---|
Book Value | 100.00 | 2.81 | 0.00 | |
Cash | 100.00 | 1.72 | 0.00 | |
Capex | -100.00 | -0.05 | 0.00 | |
Free Cash Flow | 100.00 | 0.17 | 0.00 | |
Revenue | 100.00 | 0.68 | 0.00 | |
Naive Interpretation | member |
3
Profitability
Metric | Q2 | Q4 | Δ in % | |
---|---|---|---|---|
Gross Margin | 100.00 | 0.76 | 0.00 | |
Operating Margin | 100.00 | 0.32 | 0.00 | |
ROA | n.A. | 0.04 | n.A. | |
ROE | n.A. | 0.05 | n.A. | |
ROIC | n.A. | 0.06 | n.A. | |
Naive Interpretation | member |
4
Valuation
The "Valuation Entry" for the Focus of 2172.HK is permitted for members.
5
Growth
The "Growth Entry" for the Focus of 2172.HK is permitted for members.
6
Leverage & Liquidity